AbstractThe N‐heterocyclic carbene palladium complex (SIPr)Pd(cinnamyl)Cl [SIPr=N,N′‐bis(2,4,6‐trimethylphenyl)‐4,5‐dihydroimidazol‐2‐ylidene) promotes regio‐ and stereospecific dimerization of a variety of arylalkynes to give (E)‐1,3‐enynes in good to excellent yields. An efficient and practical procedure for their synthesis was developed using a biphasic aqueous alkali/heptane system. Optical and electronic properties of (E)‐1,3‐enynes are highly tunable. Depending on the nature of the substituents, HOMO energies vary in the range 5.3–6.0 eV. (E)‐1,3‐Enynes can exhibit intense photoluminescence in the spectral region 350–500 nm.magnified image
申请人:Hubei Bio-Pharmaceutical Industrial Technological Institute Inc.
公开号:US20170313683A1
公开(公告)日:2017-11-02
Provided are a series of BTK inhibitors, and specifically disclosed are a compound, pharmaceutically acceptable salt thereof, tautomer thereof or prodrug thereof represented by formula (I), (II), (III) or (IV).
Iron‐Catalyzed Tertiary Alkylation of Terminal Alkynes with 1,3‐Diesters via a Functionalized Alkyl Radical
作者:Ming‐Qing Tian、Zhen‐Yao Shen、Xuefei Zhao、Patrick J. Walsh、Xu‐Hong Hu
DOI:10.1002/anie.202100641
日期:2021.4.19
Direct oxidative C(sp)−H/C(sp3)−H cross‐coupling offers an ideal and environmentally benign protocol for C(sp)−C(sp3) bond formations. As such, reactivity and site‐selectivity with respect to C(sp3)−H bond cleavage have remained a persistent challenge. Herein is reported a simple method for iron‐catalyzed/silver‐mediated tertiary alkylation of terminal alkynes with readily available and versatile 1
A highly efficient organo-catalytic protocol for the trimethylsilylation of terminal alkynes and N-silylation of indoles employing Ruppert's reagent as a trimethylsilyl source have been developed under solvent and fluoride free conditions.
A series of 66 new indolone-N-oxide derivatives was synthesized with three different methods. Compounds were evaluated for in vitro activity against CQ-sensitive (3D7), CQ-resistant (FcB1), and CQ and pyrimethamine cross-resistant (K1) strains of Plasmodium falciparum (P.f.), its well as for cytotoxic concentration (CC50) on MCF7 and KB human tumor Cell lines. Compound 26 (5-methoxy-indolone-N-oxide analogue) had the most potent antiplasmodial activity in vitro (< 3 nM on FcB1 and = 1.7 nM on 3D7) with a very satisfactory selectivity index (CC50 MCF7/IC50 FcB1: 14623; CC50 KB/IC50 3D7: 198823). In in vivo experiments, compound 1 (dioxymethylene derivatives of the indolone-N-oxide) showed the best antiplasmodial activity against Plasmodium berghei, 62% inhibition of the parasitaemia at 30 mg/kg/day.